The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death

BACKGROUND: Identifying the patients with hypertrophic cardiomyopathy (HCM) in whom the risk of sudden cardiac death (SCD) justifies the implantation of a cardioverter-defibrillator (ICD) in primary prevention remains challenging. Different risk stratification and criteria are used by the European a...

Descripción completa

Detalles Bibliográficos
Autores principales: Freitas, Pedro, Ferreira, António Miguel, Arteaga-Fernández, Edmundo, de Oliveira Antunes, Murrilo, Mesquita, João, Abecasis, João, Marques, Hugo, Saraiva, Carla, Matos, Daniel Nascimento, Rodrigues, Rita, Cardim, Nuno, Mady, Charles, Rochitte, Carlos Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694533/
https://www.ncbi.nlm.nih.gov/pubmed/31412875
http://dx.doi.org/10.1186/s12968-019-0561-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694533/
https://www.ncbi.nlm.nih.gov/pubmed/31412875
http://dx.doi.org/10.1186/s12968-019-0561-4

Ejemplares similares